These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35236057)

  • 1. Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation.
    Einarsdottir S; Martner A; Nicklasson M; Wiktorin HG; Arabpour M; Törnell A; Vaht K; Waldenström J; Ringlander J; Bergström T; Brune M; Hellstrand K; Ljungman P; Lagging M
    Haematologica; 2022 Jun; 107(6):1479-1482. PubMed ID: 35236057
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients.
    Easdale S; Shea R; Ellis L; Bazin J; Davis K; Dallas F; Thistlethwayte E; Ethell M; Potter M; Arias C; Anthias C; Nicholson E
    Transplant Cell Ther; 2021 Oct; 27(10):880.e1-880.e4. PubMed ID: 34293520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation.
    Huang A; Cicin-Sain C; Pasin C; Epp S; Audigé A; Müller NJ; Nilsson J; Bankova A; Wolfensberger N; Vilinovszki O; Nair G; Hockl P; Schanz U; Kouyos RD; Hasse B; Zinkernagel AS; Trkola A; Manz MG; Abela IA; Müller AMS
    Transplant Cell Ther; 2022 Apr; 28(4):214.e1-214.e11. PubMed ID: 35092892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: mRNA SARS-CoV-2 vaccination in patients after allogeneic hematopoietic cell transplantation.
    Mungmunpuntipantip R; Wiwanitkti V
    Transpl Infect Dis; 2022 Jun; 24(3):e13839. PubMed ID: 35419913
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral Immunity After mRNA SARS-CoV-2 Vaccination in Allogeneic HCT Recipients-Room for Improvement and Much to Learn.
    Hill JA
    JAMA Netw Open; 2021 Sep; 4(9):e2127454. PubMed ID: 34519771
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Mamez AC; Pradier A; Giannotti F; Petitpas A; Urdiola MF; Vu DL; Masouridi-Levrat S; Morin S; Dantin C; Clerc-Renaud D; Eberhardt CS; Kaiser L; Simonetta F; Chalandon Y
    Bone Marrow Transplant; 2021 Dec; 56(12):3094-3096. PubMed ID: 34584239
    [No Abstract]   [Full Text] [Related]  

  • 7. Beginning to understand clinical events and immune responses of hematopoietic cell transplant recipients receiving SARS-CoV-2 vaccination.
    Young JH
    Transplant Cell Ther; 2021 Sep; 27(9):700-701. PubMed ID: 34452720
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
    Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
    Front Immunol; 2022; 13():906225. PubMed ID: 35720376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.
    Redjoul R; Le Bouter A; Parinet V; Fourati S; Maury S
    Lancet Haematol; 2021 Oct; 8(10):e681-e683. PubMed ID: 34487683
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: Concerns.
    Daungsupawong H; Wiwanitkit V
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1111. PubMed ID: 38679969
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and HSCT (Hematopoietic stem cell transplant).
    Strasfeld L
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101399. PubMed ID: 36494150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients.
    Abid MB; Rubin M; Ledeboer N; Szabo A; Longo W; Mohan M; Shah NN; Fenske TS; Abedin S; Runaas L; D'Souza A; Chhabra S; Dhakal B; Hamadani M
    Cancer Cell; 2022 Apr; 40(4):340-342. PubMed ID: 35202585
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?
    Sengsayadeth S; Broglie L; Savani BN
    Br J Haematol; 2022 Feb; 196(4):809-811. PubMed ID: 34850381
    [No Abstract]   [Full Text] [Related]  

  • 14. T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Pradier A; Mamez AC; Stephan C; Giannotti F; Masouridi-Levrat S; Wang S; Morin S; Neofytos D; Vu DL; Melotti A; Arm I; Eberhardt CS; Tamburini J; Kaiser L; Chalandon Y; Simonetta F
    Ann Oncol; 2022 Dec; 33(12):1333-1335. PubMed ID: 36116692
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-COV-2 vaccination after stem cell transplantation for scleroderma.
    Rimar D; Slobodin G; Paz A; Henig I; Zuckerman T
    Ann Rheum Dis; 2021 Oct; 80(10):1354-1355. PubMed ID: 34049853
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on "SARS-CoV-2 vaccine safety and COVID-19 risk perception in hematopoietic stem cell transplant recipients".
    Mungmunpuntipantip R; Wiwanitkit V
    Support Care Cancer; 2023 Dec; 32(1):51. PubMed ID: 38129605
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation.
    Wiktorin HG; Einarsdottir S; Törnell A; Arabpour M; Issdisai N; Waldenström J; Ringlander J; Lindh M; Lagging M; Hellstrand K; Martner A
    Haematologica; 2022 Oct; 107(10):2492-2495. PubMed ID: 35734932
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT.
    Leclerc M; Redjoul R; Le Bouter A; Beckerich F; Robin C; Parinet V; Pautas C; Menouche D; Bouledroua S; Roy L; Cabanne L; Nait-Sidenas Y; Harfouch E; Gautier E; Fourati S; Maury S
    Lancet Haematol; 2022 May; 9(5):e318-e321. PubMed ID: 35378072
    [No Abstract]   [Full Text] [Related]  

  • 19. Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients.
    Leclerc M; Redjoul R; Le Bouter A; Beckerich F; Robin C; Parinet V; Pautas C; Menouche D; Bouledroua S; Roy L; Cabanne L; Nait-Sidenas Y; Fourati S; Maury S
    J Hematol Oncol; 2022 Mar; 15(1):27. PubMed ID: 35303906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and "booster" dose.
    Attolico I; Tarantini F; Carluccio P; Musto P
    Haematologica; 2022 May; 107(5):1218. PubMed ID: 35045696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.